Real-world experience with the use of emicizumab in paediatric haemophilia A patients with and without inhibitors

被引：0
|
作者：
Lam, Joyce Ching Mei [1 ]
Lim, Chiew Ying [1 ]
Kadir, Nur Insyirah Abdul [1 ]
机构：
[1] KK Womens & Childrens Hosp, Singapore, Singapore
来源：
HAEMOPHILIA | 2022年 / 28卷
关键词：
Emicizumab; paediatric haemophilia patients with and without inhibitors; real world experience;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP-11 (115
引用
收藏
页码：50 / 51
页数：2
相关论文
共 50 条
  • [1] Real-world data on the use of emicizumab in patients with haemophilia A with and without inhibitors in Singapore
    Lee, Ming Wei
    Cheong, May Anne
    Ng, Heng Joo
    Tien, Sim Leng
    Lam, Joyce Ching Mei
    [J]. ANNALS ACADEMY OF MEDICINE SINGAPORE, 2023, 52 (11) : 580 - 589
  • [2] Real-world experience on the tolerability and safety of emicizumab prophylaxis in paediatric patients with severe haemophilia A with and without FVIII inhibitors
    Hassan, Eman
    Jonathan, Lancashire
    Jayashree, Motwani
    [J]. HAEMOPHILIA, 2021, 27 (06) : E698 - E703
  • [3] EMICIZUMAB PROPHYLAXIS IN ADULT AND PAEDIATRIC HAEMOPHILIA A PATIENTS WITHOUT INHIBITORS: A SINGLE CENTRE REAL WORLD EXPERIENCE
    Catalano, A.
    Di Gregorio, P.
    Di Cocco, M. L.
    Malizia, R.
    Paolini, F.
    Verna, S.
    [J]. HAEMOPHILIA, 2021, 27 : 70 - 70
  • [4] Real-World Use of Emicizumab in Patients with Hemophilia with and without Inhibitors
    McCary, Isabella
    Guelcher, Christine
    Kuhn, Jan
    Butler, Regina
    Massey, Gita
    Guerrera, Michael F.
    Ballester, Lance
    Raffini, Leslie J.
    [J]. BLOOD, 2019, 134
  • [5] EMICIZUMAB PROPHYLAXIS IN HAEMOPHILIA A WITH AND WITHOUT INHIBITORS: REAL-WORLD DATA FROM SLOVENIA
    Rener, K.
    Doma, S. Anzej
    Kotnik, B. Faganel
    Kitanovski, L.
    Fink, M.
    Zupan, I. Preloznik
    [J]. HAEMOPHILIA, 2021, 27 : 70 - 70
  • [6] REAL-WORLD SAFETY AND EFFICACY OF EMICIZUMAB IN HAEMOPHILIA A WITH INHIBITORS IN THE UK
    Wall, C.
    Hall, G.
    Scott, M.
    Collins, P. W.
    Maclean, R.
    Xiang, H.
    Hay, C. R.
    Hart, D. P.
    Anderson, J.
    Dolan, G.
    Symington, E.
    [J]. HAEMOPHILIA, 2020, 26 : 64 - 65
  • [7] Real-world data for the use of emicizumab in haemophilia A patients with inhibitors - First nationwide report from Korea
    Hahn, Seung Min
    Han, Jung Woo
    Kim, Jin Seok
    Shim, Ye Jee
    Kim, Soyon
    Kim, Hugh Chul
    Park, Young Shil
    Lyu, Chuhl Joo
    [J]. HAEMOPHILIA, 2023, 29 (04) : 1163 - 1166
  • [8] Real-world use of emicizumab in patients with haemophilia A: Bleeding outcomes and surgical procedures
    McCary, Isabella
    Guelcher, Christine
    Kuhn, Jan
    Butler, Regina
    Massey, Gita
    Guerrera, Michael F.
    Ballester, Lance
    Raffini, Leslie
    [J]. HAEMOPHILIA, 2020, 26 (04) : 631 - 636
  • [9] Real experience of prophylaxis with emicizumab in patients with congenital haemophilia A with and without FVIII inhibitors in the HCUVA
    Heredia Cano, Angela
    Garcia Candel, Faustino
    Sanchez Villalobos, Maria
    Poveda Garcia, Andrea
    Torchia Esteban, Marcos
    Ruiz Ruiz, Estela
    Sanchez Salas, Jose Antonio
    Navarro Almenzar, Begona
    Caracena Lopez, Sara
    Perez Laencina, Marta
    Blazquez Soto, Juan Antonio
    [J]. HAEMOPHILIA, 2024, 30 : 31 - 32
  • [10] REAL-WORLD EFFICACY OF EMICIZUMAB PROPHYLAXIS IN PATIENTS WITH SEVERE HAEMOPHILIA A WITHOUT INHIBITORS: A REPORT FROM THE UK HAEMOPHILIA CENTRE DOCTORS' ORGANISATION
    Wall, C.
    Xiang, H.
    Palmer, B.
    Collins, P. W.
    Stephensen, D.
    Scott, M.
    Chalmers, E.
    Chowdary, P.
    Hall, G. W.
    Liesner, R.
    Hart, D. P.
    Shapiro, S.
    Talks, K.
    Fletcher, S.
    Hay, C. R.
    [J]. HAEMOPHILIA, 2021, 27 : 116 - 116
12345